You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Enigma struck the alliance with Tecan in anticipation of a fourth-quarter commercial launch of its miniaturized PCR instrument for point-of-care influenza diagnostic tests in Europe in partnership with GlaxoSmithKline.
Tecan will manufacture Enigma's new point-of-care molecular diagnostic instrument under a five-year deal.
Chris Wagner, Brad Popovich, Jorge Garces, Greg Hamilton, Nick Williams, Darren Hall
The British molecular diagnostics firm also announced executive appointments for both the US and European operations.
The firms will develop tests to run on Enigma's ML platform. As part of the alliance, GSK will make an equity investment in the molecular diagnostics startup.
Enigma Diagnostics gained access to two Roche patents for use in its multiplex PCR tests for human and animal diseases.
In Brief This Week is a Friday column containing news items that our readers may have missed during the week.
Politico notes that the Biden Administration has not yet nominated a permanent Food and Drug Administration commissioner.
Anthony Fauci also informed the World Health Organization executive board that the US would be joining the COVAX initiative, according to CNBC.
A new preprint suggests some SARS-CoV-2 variants could affect the effectiveness of current vaccines, the Associated Press reports.
In Nature this week: Australian lungfish provides details on the movement of vertebrate life from water to land, and more.